Methicillin-Resistant *Staphylococcus Aureus* (MRSA) is a bacterium occupying the skin and nasal lining of 25-30% of healthy individuals. It can cause several difficult-to treat infections in humans.\[[@ref1]\]

MRSA is a strain which acquired resistant to beta-lactam antibiotics and Cephalosporins. MRSA was first described in 1961 and had spread later throughout the world. Its prevalence had increased in hospitals, prisons, nursing homes and community settings. The term Healthcare-Associated MRSA (HA-MRSA) and Community-Associated MRSA (CA-MRSA) is reflecting this condition.\[[@ref2]\]

The prevalence of antimicrobial resistance in hospital-acquired *S. aureaus* infections (HA-MRSA) has been progressively increased since its first description worldwide.\[[@ref3][@ref4][@ref5]\] CA-MRSA, reported in 1980 among injection drug-users, became the most frequent cause of skin and soft tissue infection worldwide.\[[@ref6][@ref7]\]

MRSA has been described and reported from Saudi Arabia since 1990.\[[@ref8][@ref9]\] In this issue, Dr. Sulaiman Al-Yousef reviews Methicillin-Resistant Staphylococcus Aureus in Saudi Arabia and its genotype distribution.
